Functional evaluation after reconstruction of the anterior floor of the mouth with free flaps in patients with head and neck cancer

Clinical and Translational Oncology

Volumn 4, Issue 3, 2002, Pages 133-138

  Ortiz, Kuauhyama Luna ^a,b   Jaques, Bertrand ^a   Monnier, Philippe ^a   Pasche, Philippe ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

Floor of the mouth; Functional evaluation; Head and neck cancer; Quality of life

Indexed keywords

EID: 30844471198     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: None     Document Type: Article

References (78)

1. Ellis M, Chew YP, Fallis L, et al. Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex. Embo J 1999;18:644-53.
2. Mann DJ, Child ES, Swanton C, et al. Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus. Embo J 1999; 18:654-63.
3. Ojala PM, Tiainen M, Salven P, et al. Kaposi's sarcomaassociated herpesvirus-encoded v-cyclin triggers apoptosis in cells with high levels of cyclin-dependent kinase 6. Cancer Res 1999;59:4984-9.
4. Ojala PM, Yamamoto K, Castanos-Velez E, Biberfeld P, Korsmeyer SJ, Makela TP. The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2. Nat Cell Biol 2000;2:819-25.
5. Dittmer D, Lagunoff M, Renne R, et al. A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J Virol 1998;72: 8309-15.
6. Sarid R, Wiezorek JS, Moore PS, et al. Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter. J Virol 1999;73:1438-46.
7. Talbot SJ, Weiss RA, Kellam P, et al. Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, 74 in a primary effusion lymphoma cell line. Virology 1999;257:84-94.
8. Davis MA, Sturzl MA, Blasig C, et al. Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cells. J Natl Cancer Inst 1997;89:1868-74.
9. Reed JA, Nador RG, Spaulding D, et al. Demonstration of Kaposi's sarcoma-associated herpes virus cyclin D homolog in cutaneous Kaposi's sarcoma by colorimetric in situ hybridization using a catalyzed signal amplification system. Blood 1998;91:3825-32.
10. Platt GM, Cannell E, Cuomo ME, et al. Detection of the human herpesvirus 8-encoded cyclin protein in primary effusion lymphoma-derived cell lines. Virology 2000; 272:257-66.
11. Arvanitakis L, Geras-Raaka E, Varma A, et al. Human herpesvirus KSHV encodes a constitutively active Gprotein-coupled receptor linked to cell proliferation. Nature 1997;385:347-50.
12. Ho HH, Ganeshalingam N, Rosenhouse-Dantsker A, et al. Charged residues at the intracellular boundary of transmembrane helices 2 and 3 independently affect constitutive activity of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. J Biol Chem 2001;276:1376-82.
13. Gershengorn MC, Geras-Raaka E, Varma A, et al. Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture. J Clin Invest 1998;102:1469-72.
14. Geras-Raaka E, Varma A, Ho H, et al. Human interferon-gamma-inducible protein 10 (IP-10) inhibits constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. J Exp Med 1998;188: 405-8.
15. Geras-Raaka E, Varma A, Clark-Lewis I, et al. Kaposi's sarcoma-associated herpesvirus (KSHV) chemokine vMIP-II and human SDF-1alpha inhibit signaling by KSHV G protein-coupled receptor. Biochem Biophys Res Commun 1998;253:725-7.
16. Ho HH, Du D, Gershengorn MC. The N terminus of Kaposi 's sarcoma-associated herpesvirus G protein-coupled receptor is necessary for high affinity chemokine binding but not for constitutive activity. J Biol Chem 1999;274:31327-32.
17. Lupu-Meiri M, Silver RB, Simons AH, et al. Constitutive signaling by Kaposi's sarcoma-associated herpesvirus G-protein-coupled receptor desensitizes calcium mobilization by other receptors. J Biol Chem 2001;276:7122-8.
18. Geras-Raaka E, Arvanitakis L, Bais C, et al. Inhibition of constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor by protein kinases in mammalian cells in culture. J Exp Med 1998;187: 801-6.
19. Bais C, Santomasso B, Coso O, et al. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 1998; 391:86-9.
20. Munshi N, Ganju RK, Avraham S, et al. Kaposi's sarcoma-associated herpesvirus-encoded G protein-coupled receptor activation of c-jun amino-terminal kinase/ stress-activated protein kinase and lyn kinase is mediated by related adhesion focal tyrosine kinase/ prolinerich tyrosine kinase 2. J Biol Chem 1999;274: 31863-7.
21. Sodhi A, Montaner S, Patel V, et al. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. Cancer Res 2000; 60:4873-80.
22. Montaner S, Sodhi A, Pece S, et al. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B. Cancer Res 2001; 61:2641-8.
23. Kirshner JR, Staskus K, Haase A, et al. Expression of the open reading frame 74 (G-protein-coupled receptor) gene of Kaposi's sarcoma (KS)-associated herpesvirus: implications for KS pathogenesis. J Virol 1999;73:6006-14.
24. Rainbow L, Platt GM, Simpson GR, et al. The 222 to 234-kilodalton latent nuclear protein (LNA) of Kaposi 's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol 1997;71:5915-21.
25. Kellam P, Boshoff C, Whitby D, et al. Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome. J Hum Virol 1997;1:19-29.
26. Platt GM, Simpson GR, Mittnacht S, et al. Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene. J Virol 1999;73: 9789-95.
27. Schwam DR, Luciano RL, Mahajan SS, et al. Carboxy terminus of human herpesvirus 8 latency-associated nuclear antigen mediates dimerization, transcriptional repression, and targeting to nuclear bodies. J Virol 2000;74: 8532-40.
28. Krithivas A, Young DB, Liao G, et al. Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells. J Virol 2000;74:9637-45.
29. Ballestas ME, Chatis PA, Kaye KM. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 1999;284:641-4.
30. Szekely L, Kiss C, Mattsson K, et al. Human herpesvirus-8-encoded LNA-1 accumulates in heterochromatin-associated nuclear bodies. J Gen Virol 1999;80:2889-900.
31. Lim C, Sohn H, Gwack Y, et al. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) binds ATF4/CREB2 and inhibits its transcriptional activation activity. J Gen Virol 2000;81 Pt 11:2645-52.
32. Friborg J, Jr., Kong W, Hottiger MO, et al. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 1999;402:889-94.
33. Radkov SA, Kellam P, Boshoff C. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med 2000;6:1121-7.
34. Zong JC, Ciufo DM, Alcendor DJ, et al. High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations. J Virol 1999;73:4156-70.
35. Lee H, Guo J, Li M, et al. Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus. Mol Cell Biol 1998; 18:5219-28.
36. Lagunoff M, Majeti R, Weiss A, et al. Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci USA 1999; 96:5704-9.
37. Lee H, Veazey R, Williams K, et al. Deregulation of cell growth by the K1 gene of Kaposi's sarcoma associated herpesvirus. Nat Med 1998;4:435-40.
38. Sadler R, Wu L, Forghani B, et al. A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi 's sarcoma-associated herpesvirus. J Virol 1999;73:5722-30.
39. Muralidhar S, Veytsmann G, Chandran B, et al. Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12). J Clin Virol 2000; 16:203-13.
40. Muralidhar S, Pumfery AM, Hassani M, et al. Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene. J Virol 1998;72:4980-8.
41. Kliche S, Nagel W, Kremmer E, et al. Signaling by human herpesvirus 8 kaposin A through direct membrane recruitment of cytohesin-1. Mol Cell 2001;7:833-43.
42. Zimring JC, Goodbourn S, Offermann MK. Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. J Virol 1998;72:701-7.
43. Li M, Lee H, Guo J, et al. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor. J Virol 1998;72:5433-40.
44. Gao SJ, Boshoff C, Jayachandra S, et al. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene 1997;15:1979-85.
45. Burysek L, Yeow WS, Lubyova B, et al. Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. J Virol 1999;73: 7334-42.
46. Lin R, Genin P, Mamane Y, et al. HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene 2001;20:800-11.
47. Nakamura H, Li M, Zarycki J, et al. Inhibition of p53 tumor suppressor by viral interferon regulatory factor. J Virol 2001;75:7572-82.
48. Burysek L, Yeow WS, Pitha PM. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2). J Hum Virol 1999;2:19-32.
49. Rivas C, Thlick AE, Parravicini C, et al. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J Virol 2001;75:429-38.
50. Lubyova B, Pitha PM. Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors. J Virol 2000;74:8194-201.
51. Poole LJ, Zong JC, Ciufo DM, et al. Comparison of genetic variability at multiple 'oci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand end. J Virol 1999;73:6646-60.
52. Choi JK, Lee BS, Shim SN, et al. Identification of the novel K15 gene at the rightmost end of the Kaposi's sarcoma-associated herpesvirus genome. J Virol 2000; 74:436-46.
53. Lin SF, Robinson DR, Miller G, et al. Kaposi's sarcomaassociated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein-Barr virus. J Virol 1999; 73:1909-17.
54. Park J, Seo T, Hwang S, et al. The K-bZIP protein from Kaposi's sarcoma-associated herpesvirus interacts with p53 and represses its transcriptional activity. J Virol 2000; 74:11977-82.
55. Polson AG, Huang L, Lukac DM, et al. Kaposi's sarcoma-associated herpesvirus K-bZIP protein is phosphorylated by cyclin-dependent kinases. J Virol 2001; 75:3175-84.
56. Zhu FX, Cusano T, Yuan Y. Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirus. J Virol 1999;73:5556-67.
57. Lukac DM, Kirshner JR, Ganem D. Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J Virol 1999;73:9348-61.
58. Gwack Y, Hwang S, Byun H, et al. Kaposi's sarcomaassociated herpesvirus open reading frame 50 represses p53-induced transcriptional activity and apoptosis. J Virol 2001;75:6245-8.
59. Seaman WT, Ye D, Wang RX, et al. Gene expression from the ORF50/K8 region of Kaposi's sarcoma-associated herpesvirus. Virology 1999; 263:436-49.
60. Djerbi M, Screpanti V, Catrina AI, et al. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J Exp Med 1999;1 90:1025-32.
61. Belanger C, Gravel A, Tomoiu A, et al. Human herpesvirus 8 viral FLICE-inhibitory protein inhibits Fasmediated apoptosis through binding and prevention of procaspase-8 maturation. J Hum Virol 2001;4:62-73.
62. Chaudhary PM, Jasmin A, Eby MT, et al. Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins. Oncogene 1999;18:5738-46.
63. Bieleski L, Talbot SJ. Kaposi's sarcoma-associated herpesvirus vCyclin open reading frame contains an internal ribosome entry site. J Virol 2001;75:1864-9.
64. Sturzl M, Hohenadl C, Zietz C, et al. Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells. J Natl Cancer Inst 1999;91:1725-33.
65. Cheng EH, Nicholas J, Bellows DS, et al. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci U S A 1997; 94:690-4.
66. Sarid R, Sato T, Bohenzky RA, et al. Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat Med 1997;3:293-8.
67. Ascherl G, Hohenadl C, Monini P, et al. Expression of human herpesvirus-8 (HHV-8) encoded pathogenic genes in Kaposi's sarcoma (KS) primary lesions. Adv Enzyme Regul 1999;39:331-9.
68. Sodhi A, Montaner S, Miyazaki H, et al. MAPK and Akt Act Cooperatively but Independently on hypoxia inducible factor-1alpha in rasV12 Upregulation of VEGF. Biochem Biophys Res Commun 2001;287:292-300.
69. Yang TY, Chen SC, Leach MW, et al. Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J Exp Med 2000;191:445-54.
70. Moore PS, Boshoff C, Weiss RA, et al. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996;274:1739-44.
71. Neipel F, Albrecht JC, Ensser A, et al. Human herpesvirus 8 encodes a homolog of interleukin-6. J Virol 1997; 71:839-42.
72. Nicholas J, Ruvolo VR, Burns WH, et al. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6 Nat Med 1997; 3: 287-92.
73. Molden J, Chang Y, You Y, et al. A Kaposi's sarcomaassociated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem 1997; 272:19625-31.
74. Wan X, Wang H, Nicholas J. Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6. J Virol 1999;73:8268-78.
75. Hideshima T, Chauhan D, Teoh G, et al. Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virusencoded viral interleukin 6. Clin Cancer Res 2000; 6:1180-9.
76. Aoki Y, Jaffe ES, Chang Y, et al. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood 1999;93:4034-43.
77. Aoki Y, Yarchoan R, Wyvill K, et al. Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesviruslinked disorders. Blood 2001; 97:2173-6.
78. Staskus KA, Sun R, Miller G, et al. Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary